Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences:
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2024 Financial Results Conference […]
Aligns with EPS Projections Amidst Financial and Operational Developments